Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1061 | 1169 | 917 | 702 | 1152 | 1790 |
Fund Return | 6.07% | 16.86% | -8.31% | -11.14% | 2.87% | 5.99% |
Place in category | 86 | 198 | 68 | 172 | 161 | 31 |
% in Category | 14 | 32 | 14 | 50 | 71 | 64 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Morgan Stanley HX Health Industry | 2.13B | -9.17 | -19.40 | - | ||
Morgan Stanley Huaxin Multiple Fact | 562.55M | -11.44 | -8.54 | 8.06 | ||
MS Huaxin Resource Selected Mixed | 407.12M | 8.40 | -17.07 | 5.61 | ||
MS Huaxin Aggressive Growth Equity | 353.2M | -2.84 | -17.36 | - | ||
Huaxin Leading Advanced Stock | 300.41M | -7.23 | -6.41 | 9.49 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhong Ou Modern Pioneer InitiatingA | 12.25B | 7.83 | -9.69 | - | ||
TianHong ChiNext Index A | 6.81B | -1.11 | -14.35 | - | ||
TianHong ChiNext Index C | 6.81B | -1.19 | -14.52 | - | ||
ICBC Credit Literary Ids Eq | 5.51B | 6.59 | -8.76 | - | ||
Harvest Emerging Industry Eq | 5.46B | -2.33 | -17.92 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Amperex Tech A | CNE100003662 | 4.11 | 205.99 | +1.72% | |
Midea Group A | CNE100001QQ5 | 3.67 | 64.68 | -0.52% | |
Wuliangye A | CNE000000VQ8 | 2.77 | 147.84 | +1.27% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 2.67 | 298.82 | +0.75% | |
Boe Technology A | CNE0000016L5 | 2.43 | 4.14 | +1.22% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Buy | Sell |
Summary | Strong Sell | Neutral | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review